. Epidemiological studies have shown that obesity is associated with a poor prognosis of survival from breast cancer (Donegan et al., 1978; Boyd et al., 1981; Tartter et al., 1981; Zumoff & Dasgupta, 1983; Greenberg et al., 1985; Newman et al., 1986; Hebert et al., 1988; Mohle-Boetani et al., 1988; Kyogoku et al., 1990; Tretli et al., 1990; Senie et al., 1992; Bastarrachea et al., 1994 
, or reported results that show no clear-cut relationships in either pre-or postmenopausal women between breast cancer risk and obesity (Ravnihar et al., 1971; Stavraky & Emmons, 1974; Adami et al., 1977; Wynder et al., 1978) .
Current statistics reveal that breast cancer is the second leading cause of cancer mortality for women in the United States (Boring et al., 1992) . Epidemiological studies have shown that obesity is associated with a poor prognosis of survival from breast cancer (Donegan et al., 1978; Boyd et al., 1981; Tartter et al., 1981; Zumoff & Dasgupta, 1983; Greenberg et al., 1985; Newman et al., 1986; Hebert et al., 1988; Mohle-Boetani et Kyogoku et al., 1990; Tretli et al., 1990; Senie et al., 1992; Bastarrachea et al., 1994) . Our primary interest has been in studying the association of obesity with recurre and survival from breast cancer in post-menopausal women. Recognising that recurrence is a significant factor contributing to survival outcome, we have used multiple logistic regression to study recurrence and survival in obese and non-obese post-menopausal women adjusted for a number of other risk factors for breast cancer. The results of our historical prospecitve study conducted in a 500-bed teaching hospital, in which obese and non-obese post-menopausal women with breast cancer were compared in terms of recurrence and survival during a minimum foUlow-up period of 5 years, are reported. Tables II and  III. Table IV The cohort that was studied for this report had a median age of 72 years. There were slightly more than twice the number of patients who had survived the 5 year follow-up period than who had died. The distribution of our hormone receptor analyses confirmed what has been known for some time, i.e. that in post-menopausal women the ER positives outnumber the ER negatives.
Although the positives predominate for PRs, the advantage is not as great as for the ERs. Our data showed 78% ER positive and 22% ER negative, and 56% PR positive and 44% PR negative. This is consistent with the results of other similar analyses of hormone receptors in post-menopausal women (Howell et al., 1984; Cooper et al., 1989; Shek & Godolphin, 1989) .
The univariate association between each variable and case fatality (Table II) [1.24, 8 .70] Note: Race was not used in this model because of the small sample size for black women (n = 18). 'Derived using multiple logistic regression. The appropriateness of fit of the model was evaluated using the Hosmer-Lemeshow chi-square statistic.
women, among whom 136 (45%) were obese. Obesity was the only significnt prognostic factor g from multivariate analysis that controlled for tumour size, number of positive nodes, age at diagnosis and adjuvant chemotherapy with a hazard ratio of 1.29 (Senie et at., 1992) . This contrasts with our data, which by multivariate analysis showed that level of treatment, stage I, size of tumour and >4 positive nodes but not obesity, were significantly associated with recurrence (Table V) . In a more recent study by Bastarrachea et al. (1994) , an association was found by multivariate analysis for breast cancer recurrence (relative risk of 1.33) among obese patients. This was studied in 735 consecutive patients with primary breast cancer who had undergone surgery with subsequent adjuvant chemotherapy. Of interest here was the persistence of the prognostic effect of obesity even with adjuvant chemotherapy.
Another recent study (Daniell et al., 1993) showed that obesity and smoking are related to larger lymph node metastases. This was explained by a more rapid growth of metastatic tissues in both obese women and smokers, coupled with an earlier onset of metastasis from their primary breast cancers. The development of earlier and larger metastases in obese women could be attributed to impaired immunity (Chandra & Kutty, 1980 (Weber et al., 1985 (Weber et al., , 1987 . Adipocytes with enhanced angiogenic potential could also be a factor in early cancer metastasis in obese women (Castellot et al., 1980 (Tartter et al., 1981; Newman et al., 1986; Kyogoku et al., 1990) . Others have found obesity and poorer survival only in the early stages of breast cancer (Donegan et al., 1978; Boyd et al., 1981; Hebert et al., 1988; Tretli et al., 1990) , while Greenberg et al. (1985) found a significant trend towards lower survival with increasng weight in premenopausal breast cancer patients. In contrast to these reports. Ewertz et al. (1991) found an increased risk of dying from breast cancer associated with low body weight. However, this was in subjects with stage IV or advanced breast cancer.
The overall results of this study showed that no significant association could be demonstrated between obesity (using the Quetelet index) and recurrence or death from breast cancer. (Wynder & Cohen, 1982; Wynder et al.. 1990; Chlebowski et al., 1991; Cohen et al., 1993 
